β-site APP-cleaving enzyme 1
β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage
... the β-site APP-cleaving enzyme 1 (BACE1, β-secretase) [3] and γ-secretase ...cleaves APP at the first amino acid of the Aβ domain and is crucial for the production ...
8
Physiochemical features for designing novel B-site APP-cleaving enzyme 1 inhibitor against Alzheimer’s
... Background: Β-site APP-cleaving enzyme 1 (BACE-1) is a target protein for therapeutic treatment of Alzheimer’s ...(subs 1) and bond lipole (subs 2), are positively ...
6
The role of APP and BACE1 trafficking in APP processing and amyloid-β generation
... ( β -site APP cleaving enzyme 1) and γ -secretase are important enzymes in this ...of APP and enzymes is essential for APP processing and A β production but ...
8
Critical analysis of the use of β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in the treatment of Alzheimer's disease
... Figure 1 Disruption of the processing balance of the amyloid precursor protein (APP) in Alzheimer’s ...The APP can be processed through two alternative ...pathway), APP is cleaved by α-sec, ...
19
Sorting nexin-4 regulates β-amyloid production by modulating β-site-activating cleavage enzyme-1
... disease; APP: Amyloid precursor protein; A β : β -Amyloid; BACE1: β -Site amyloid precursor protein-cleaving enzyme 1; CTF: C-terminal fragment; EDTA: ...
14
Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
... proteases: β -site APP- cleaving enzyme (BACE) and ...in APP and the catalytic subunit of γ -secretase, presenilin, cause inherited forms of AD (familial AD (FAD)) with ...
12
Zhu, Kaichuan (2018): β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibition impairs synaptic plasticity via seizure protein 6 (SZE6). Dissertation, LMU München: Fakultät für Chemie und Pharmazie
... Notch signaling, are affected by chronic inhibition of the γ-secretase complex (Bittner et al., 2009; De Strooper, 2014). Immunotherapy studies have shown only marginal disease modification, although it has been reported ...
105
Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer’s disease mouse model
... A β : amyloid β peptide; AD: Alzheimer ’ s disease; APH-1: anterior pharynx- defective 1; APP: amyloid β precursor protein; BACE-1: β -site amyloid precursor ...
10
EXTRACTION AND IN VITRO SCREENING OF POTENTIAL ACETYLCHOLINESTERASE, BUTYRYLCHOLINESTERASE AND BACE1 INHIBITORS FROM THE LEAVES OF OCIMUM SANCTUMRajbongshi Lata, Rahman Azizur, Rahman Mizanur, Howlader Saurav*DOWNLOAD/VIEW
... by β-site amyloid precursor protein cleaving enzyme 1 (BACE1) and γ- secretase ...of APP increased the production and accumulation of neurotoxic forms of Aβ in the ...
8
Trafficking regulation of proteins in Alzheimer’s disease
... beta-site APP-cleaving enzyme 1 (BACE1) is the dominant β-secetase enzyme for APP ...inhibits APP processing and Aβ generation both in vitro and in vivo ...
13
Angiotensins and Alzheimer's disease: a bench to bedside overview
... A β load and increased A β deposition in blood vessels (that is, cerebral amyloid angiopathy) [21-23] (see [23,24] for reviews) - as well as increased AngII and AngII receptor (AT 1 R, AT 2 R) ...
8
BACE2, a conditional β-secretase, contributes to Alzheimer’s disease pathogenesis
... that β-secretase activity instead of BACE1 is remarkably elevated in aged brains of humans, monkeys, and nontransgenic mice ...extra β-secretase activity could result from BACE1 being superactivated for ...
16
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
... The mechanisms by which these membrane-resident ADAM10 species reach the CSF are unknown, but neur- onal death may be a contributing factor. Interestingly, proADAM10 and ADAM10f were also detected in cul- ture media from ...
9
Cognitive improvement of compound danshen in an Aβ25 35 peptide induced rat model of Alzheimer’s disease
... rabbit APP/BACE1/PS1 (1:1000; Cell Signaling Technology, Danvers, MA, USA), rabbit IDE (1:6000; Abcam, Cambridge, MA, USA), rabbit NEP (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), ...
9
Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer’s disease
... the APP as well [45, 49]; compared to control subjects, NDEVs isolated from AD patients show enrichment of undigested lysosomal APP C-terminal fragments ...
9
Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors
... In contrast to these connections to pathology, ApoE provides neuroprotection in many paradigms, and ApoE deficiency has proved detrimental in several respects [64]. Therefore, inductions of ApoE by the stimuli we tested ...
12
Perspectives and applications of immobilised β galactosidase in food industry – a review
... immobilised β -galac- tosidase should be stable at high temperature, low water content and giving high transgalactosylation ...of β -galactosidases applied in GOS produc- tion were some types of ...
14
Oxysterol-binding protein-1 (OSBP1) modulates processing and trafficking of the amyloid precursor protein
... OSBP1, APP, and APP-CTFs expres- sion levels in HEK-APPNFEV, cell monolayers were washed twice with ice-cold PBS and lysed in PBS contain- ing 1% Triton X-100, 1 mM PMSF and Complete protease ...
12
Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab
... 3D6A β 1-40: Fab 3D6 + A β residues 1 – 40; 3D6A β 1-7: Fab 3D6 + A β residues 1 – 7; AAA: amino acid analysis; AD: Alzheimer ’ s disease; APP: amyloid ...
13
Demonstration of a deficiency of glucocerebroside cleaving enzyme in Gaucher's disease
... The present observations, coupled with the earlier demonstration that cerebroside synthesis appears normal in Gaucher spleen 8, make it appear quite likely that a deficiency of activity [r] ...
5